探索与中年症状相关的Mirena使用情况
Ava Warner1, Sofiya Shreyer1, Daniel E Brown2
1Department of Anthropology, UMass Amherst, Amherst, MA.
概括
Mirena IUD的使用与中年症状增加 (如热或情绪变化) 没有联系. 这表明子宫内装置不太可能在更年期过渡期间对症状体验产生负面影响.
科学领域:
- 生殖健康 生殖健康
- 绝经研究 绝经研究
- 妇女健康研究 妇女健康研究
背景情况:
- 米雷纳宫内器械 (IUD) 通常用于严重的月经出血和避孕.
- 更年期过渡涉及各种症状,包括血管运动,心理和肌肉骨问题.
- 了解荷尔蒙避孕对更年期症状的影响对于妇女健康至关重要.
研究的目的:
- 调查Mirena IUD使用与血管运动,心理,肌肉骨和性症状的相关性.
- 为了确定Mirena IUD的使用是否会增加更年期过渡期间症状的可能性.
主要方法:
- 利用了来自45-55岁的274名参与者的数据.
- 在23名Mirena IUD使用者 (8%) 和非使用者中检查了症状患病率.
- 采用后勤回归来分析米雷娜与特定症状 (发热,夜间出汗,腿,疼痛,抑郁情绪) 的关系,并根据年龄和BMI进行调整.
主要成果:
- 在Mirena IUD使用和中年症状体验之间没有发现显著的关系.
- 更高的身体质量指数 (BMI) 与热,夜间出汗和腿部的可能性增加有关.
结论:
- Mirena IUD的使用似乎不会对中年妇女的症状经历产生不利影响.
- 研究结果表明,Mirena不太可能恶化与更年期过渡相关的症状,无论其说明 (月经出血,避孕或其他月经问题).
更多相关视频
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.5K
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
16.0K
相关概念视频
Menopause
269
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
269
Disorders of the Female Reproductive System
512
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
512
Mitral Valve Prolapse II: Assessment and Management
48
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
48
Mitral Valve Prolapse III: Nursing Management
41
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
41
Birth Control Methods
3.1K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
3.1K
Hormonal Regulation of the Menstrual Cycle
729
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
729
